BE674202A - - Google Patents
Info
- Publication number
- BE674202A BE674202A BE674202DA BE674202A BE 674202 A BE674202 A BE 674202A BE 674202D A BE674202D A BE 674202DA BE 674202 A BE674202 A BE 674202A
- Authority
- BE
- Belgium
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/22—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms directly attached to ring nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42254364A | 1964-12-31 | 1964-12-31 | |
| US49576965A | 1965-10-14 | 1965-10-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE674202A true BE674202A (https=) | 1966-06-22 |
Family
ID=27025654
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE674202D BE674202A (https=) | 1964-12-31 | 1965-12-22 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US3429890A (https=) |
| BE (1) | BE674202A (https=) |
| CH (1) | CH466295A (https=) |
| DK (1) | DK124258B (https=) |
| ES (1) | ES321389A1 (https=) |
| FR (2) | FR1473057A (https=) |
| GB (1) | GB1109786A (https=) |
| IL (1) | IL24805A (https=) |
| NL (1) | NL6517267A (https=) |
| SE (1) | SE337379B (https=) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1558341A4 (en) * | 2002-11-01 | 2010-09-08 | Paratek Pharm Innc | TRANSCRIPTION FACTOR MODULATING CONNECTIONS AND THEIR USE |
| US8436031B2 (en) | 2004-04-23 | 2013-05-07 | Paratek Pharmaceuticals, Inc. | Transcription factor modulating compounds and methods of use thereof |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3625954A (en) * | 1968-03-20 | 1971-12-07 | Pfizer | 1-aroylbenzimidazoles |
| DE1770658A1 (de) * | 1968-06-19 | 1971-11-11 | Hoechst Ag | N-Hydroxi-benzimidazole,ihre Herstellung und Verwendung als Herbicide |
| US3864351A (en) * | 1971-10-04 | 1975-02-04 | Pfizer | 1-({60 -Carboxymethoxybenzoyl-2-(2{40 -pyridyl)benzimidazoles |
| DE3609318A1 (de) * | 1986-03-20 | 1987-09-24 | Basf Ag | Phenanthroimidazol-verbindungen, verfahren zu ihrer herstellung und ihre verwendung |
| US6036530A (en) * | 1997-05-06 | 2000-03-14 | Phillips & Temro Industries Ltd. | Modular feed-through connector and mounting assembly for tank heater |
| CA2656157A1 (en) * | 2006-06-23 | 2008-10-30 | Paratek Pharmaceuticals, Inc. | Transcription factor modulating compounds and methods of use thereof |
| CA2681813A1 (en) * | 2007-03-27 | 2009-01-08 | Paratek Pharmaceuticals, Inc. | Transcription factor modulating compounds and methods of use thereof |
| EP2732819B1 (en) | 2008-02-07 | 2019-10-16 | Massachusetts Eye & Ear Infirmary | Compounds that enhance Atoh-1 expression |
| US20110059962A1 (en) * | 2009-04-22 | 2011-03-10 | Alekshun Michael N | Transcription factor modulating compounds and methods of use thereof |
| BR112012010738A2 (pt) * | 2009-11-06 | 2019-09-24 | Univ Vanderbilt | ''aril e heteroaril sulfonas como potenciadores alostéricos de mglur4,composições e métodos de tratamento de disfunção neurológica'' |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE599143A (https=) * | 1960-01-18 |
-
1965
- 1965-10-14 US US495769A patent/US3429890A/en not_active Expired - Lifetime
- 1965-12-15 IL IL24805A patent/IL24805A/xx unknown
- 1965-12-16 CH CH1735965A patent/CH466295A/de unknown
- 1965-12-21 GB GB54026/65A patent/GB1109786A/en not_active Expired
- 1965-12-21 FR FR43149A patent/FR1473057A/fr not_active Expired
- 1965-12-22 BE BE674202D patent/BE674202A/xx unknown
- 1965-12-22 ES ES0321389A patent/ES321389A1/es not_active Expired
- 1965-12-29 DK DK666765AA patent/DK124258B/da unknown
- 1965-12-30 SE SE16985/65A patent/SE337379B/xx unknown
- 1965-12-31 NL NL6517267A patent/NL6517267A/xx unknown
-
1966
- 1966-03-21 FR FR54346A patent/FR5780M/fr not_active Expired
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1558341A4 (en) * | 2002-11-01 | 2010-09-08 | Paratek Pharm Innc | TRANSCRIPTION FACTOR MODULATING CONNECTIONS AND THEIR USE |
| US8436031B2 (en) | 2004-04-23 | 2013-05-07 | Paratek Pharmaceuticals, Inc. | Transcription factor modulating compounds and methods of use thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| GB1109786A (en) | 1968-04-18 |
| NL6517267A (https=) | 1966-07-04 |
| FR5780M (https=) | 1968-02-12 |
| SE337379B (https=) | 1971-08-09 |
| FR1473057A (fr) | 1967-03-17 |
| ES321389A1 (es) | 1966-06-16 |
| DK124258B (da) | 1972-10-02 |
| US3429890A (en) | 1969-02-25 |
| CH466295A (de) | 1968-12-15 |
| IL24805A (en) | 1969-11-30 |